{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T15:44:38Z","timestamp":1763912678305,"version":"3.45.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,23]]},"DOI":"10.7759\/cureus.97562","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T15:40:20Z","timestamp":1763912420000},"source":"Crossref","is-referenced-by-count":0,"title":["In Silico Development of a Targeted Small Interfering RNA (siRNA) Sequence to Silence Goblet Cell Mucin-5AC Overexpression in Cystic Fibrosis"],"prefix":"10.7759","author":[{"given":"Jeevpreet","family":"Ahluwalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarush","family":"Katakam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal","family":"Revuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjith","family":"Satish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting GR","year":"2015","unstructured":"Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015, 16:45-56. 10.1038\/nrg3849","journal-title":"Nat Rev Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton PG","year":"2019","unstructured":"Middleton PG, Mall MA, D\u0159ev\u00ednek P, et al.. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med. 2019, 381:1809-19. 10.1056\/NEJMoa1908639","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn JS","year":"2016","unstructured":"Elborn JS. Cystic fibrosis. Lancet. 2016, 388:2519-31. 10.1016\/S0140-6736(16)00576-6","journal-title":"Lancet"},{"key":"ref4","unstructured":"Cystic Fibrosis Foundation. 2019 patient registry annual data report. (2020). Accessed. November 23, 2025: https:\/\/www.cff.org\/sites\/default\/files\/2021-10\/2019-Annual-Report.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.58.071905.105316","article-title":"Airway surface dehydration in cystic fibrosis: pathogenesis and therapy","volume":"58","author":"Boucher RC","year":"2007","unstructured":"Boucher RC. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med. 2007, 58:157-70. 10.1146\/annurev.med.58.071905.105316","journal-title":"Annu Rev Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2009-0313OC","article-title":"NF-\u03bab mediates IL-1\u03b2- and IL-17A-induced MUC5B expression in airway epithelial cells","volume":"45","author":"Fujisawa T","year":"2010","unstructured":"Fujisawa T, Chang MM, Velichko S, et al.. NF-\u03bab mediates IL-1\u03b2- and IL-17A-induced MUC5B expression in airway epithelial cells. Am J Respir Cell Mol Biol. 2010, 45:246-52. 10.1165\/rcmb.2009-0313OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200607-1011OC","article-title":"MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation","volume":"175","author":"Henke MO","year":"2007","unstructured":"Henke MO, John G, Germann M, Lindemann H, Rubin BK. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Am J Respir Crit Care Med. 2007, 175:816-21. 10.1164\/rccm.200607-1011OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2021-0359OC","article-title":"Cystic fibrosis airway mucus hyperconcentration produces a vicious cycle of mucin, pathogen, and inflammatory interactions that promotes disease persistence","volume":"67","author":"Batson BD","year":"2022","unstructured":"Batson BD, Zorn BT, Radicioni G, et al.. Cystic fibrosis airway mucus hyperconcentration produces a vicious cycle of mucin, pathogen, and inflammatory interactions that promotes disease persistence. Am J Respir Cell Mol Biol. 2022, 67:253-65. 10.1165\/rcmb.2021-0359OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00381.2023","article-title":"Normalization of Muc5b ameliorates airway mucus plugging during persistent Pseudomonas aeruginosa infection in the CFTR(-\/-) rat","volume":"327","author":"Murphree-Terry M","year":"2024","unstructured":"Murphree-Terry M, Keith JD, Oden AM, Birket SE. Normalization of Muc5b ameliorates airway mucus plugging during persistent Pseudomonas aeruginosa infection in the CFTR(-\/-) rat. Am J Physiol Lung Cell Mol Physiol. 2024, 327:L672-83. 10.1152\/ajplung.00381.2023","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112936","article-title":"Synergistic antimicrobial effects of ibuprofen combined with standard-of-care antibiotics against cystic fibrosis pathogens","volume":"11","author":"Chen Q","year":"2023","unstructured":"Chen Q, Ilanga M, Simbassa SB, Chirra B, Shah KN, Cannon CL. Synergistic antimicrobial effects of ibuprofen combined with standard-of-care antibiotics against cystic fibrosis pathogens. Biomedicines. 2023, 11:2936. 10.3390\/biomedicines11112936","journal-title":"Biomedicines"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire A","year":"1998","unstructured":"Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998, 391:806-11. 10.1038\/35888","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biophys-083012-130404","article-title":"Molecular mechanisms of RNA interference","volume":"42","author":"Wilson RC","year":"2013","unstructured":"Wilson RC, Doudna JA. Molecular mechanisms of RNA interference. Annu Rev Biophys. 2013, 42:217-39. 10.1146\/annurev-biophys-083012-130404","journal-title":"Annu Rev Biophys"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams D","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O'Riordan WD, et al.. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018, 379:11-21. 10.1056\/NEJMoa1716153","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray KK","year":"2020","unstructured":"Ray KK, Wright RS, Kallend D, et al.. Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. N Engl J Med. 2020, 382:1507-19. 10.1056\/NEJMoa1912387","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00426.2012","article-title":"Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro","volume":"305","author":"Ramachandran S","year":"2013","unstructured":"Ramachandran S, Krishnamurthy S, Jacobi AM, Wohlford-Lenane C, Behlke MA, Davidson BL, McCray PB Jr. Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro. Am J Physiol Lung Cell Mol Physiol. 2013, 305:L23-32. 10.1152\/ajplung.00426.2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.12.032","article-title":"Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium","volume":"177","author":"Urb\u00e1n P","year":"2014","unstructured":"Urb\u00e1n P, Valle-Delgado JJ, Mauro N, et al.. Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium. J Control Release. 2014, 177:84-95. 10.1016\/j.jconrel.2013.12.032","journal-title":"J Control Release"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.04.028","article-title":"Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells","volume":"191","author":"Wang W","year":"2014","unstructured":"Wang W, Sreekumar PG, Valluripalli V, et al.. Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells. J Control Release. 2014, 191:4-14. 10.1016\/j.jconrel.2014.04.028","journal-title":"J Control Release"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp553","article-title":"In vitro characterization of a miR-122-sensitive double-helical switch element in the 5' region of hepatitis C virus RNA","volume":"37","author":"D\u00edaz-Toledano R","year":"2009","unstructured":"D\u00edaz-Toledano R, Ariza-Mateos A, Birk A, Mart\u00ednez-Garc\u00eda B, G\u00f3mez J. In vitro characterization of a miR-122-sensitive double-helical switch element in the 5' region of hepatitis C virus RNA. Nucleic Acids Res. 2009, 37:5498-510. 10.1093\/nar\/gkp553","journal-title":"Nucleic Acids Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2015.09.014","article-title":"The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes","volume":"428","author":"van Zundert GC","year":"2016","unstructured":"van Zundert GC, Rodrigues JP, Trellet M, et al.. The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J Mol Biol. 2016, 428:720-5. 10.1016\/j.jmb.2015.09.014","journal-title":"J Mol Biol"},{"key":"ref20","unstructured":"AMBER 2021. University of California, San Francisco. (2021). Accessed. November 23, 2025: https:\/\/ambermd.org\/."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita M","year":"2022","unstructured":"Mirdita M, Sch\u00fctze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods. 2022, 19:679-82. 10.1038\/s41592-022-01488-1","journal-title":"Nat Methods"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005659","article-title":"OpenMM 7: rapid development of high performance algorithms for molecular dynamics","volume":"13","author":"Eastman P","year":"2017","unstructured":"Eastman P, Swails J, Chodera JD, et al.. OpenMM 7: rapid development of high performance algorithms for molecular dynamics. PLoS Comput Biol. 2017, 13:e1005659. 10.1371\/journal.pcbi.1005659","journal-title":"PLoS Comput Biol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal N","year":"2011","unstructured":"Michaud-Agrawal N, Denning EJ, Woolf TB, Beckstein O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J Comput Chem. 2011, 32:2319-27. 10.1002\/jcc.21787","journal-title":"J Comput Chem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe DR","year":"2013","unstructured":"Roe DR, Cheatham TE 3rd. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013, 9:3084-95. 10.1021\/ct400341p","journal-title":"J Chem Theory Comput"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter JD","year":"2007","unstructured":"Hunter JD. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2007, 9:90-5. 10.1109\/MCSE.2007.55","journal-title":"Comput Sci Eng"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery: structure-function correlations and clinical applications","volume":"11","author":"Xu L","year":"2021","unstructured":"Xu L, Wang X, Liu Y, et al.. Lipid nanoparticles for drug delivery: structure-function correlations and clinical applications. Annu Rev Biomed Eng. 2021, 11:1-29. 10.1002\/anbr.202100109","journal-title":"Annu Rev Biomed Eng"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-012-0077-x","article-title":"Use of nebulizers in patients with COPD","volume":"29","author":"Dhand R","year":"2014","unstructured":"Dhand R, Sohal H. Use of nebulizers in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014, 29:55-65. 10.1007\/s12325-012-0077-x","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1089\/oli.2008.0164","article-title":"Chemical modification of siRNAs for in vivo use","volume":"18","author":"Behlke MA","year":"2008","unstructured":"Behlke MA. Chemical modification of siRNAs for in vivo use. Oligonucleotides. 2008, 18:305-19. 10.1089\/oli.2008.0164","journal-title":"Oligonucleotides"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.2928","article-title":"Enzymatic recognition of hydrogen peroxide (H(2) O(2) ) in human plasma samples using HRP immobilized on the surface of poly(arginine-toluidine blue)- Fe(3) O(4) nanoparticles modified polydopamine; a novel biosensor","volume":"34","author":"Sardaremelli S","year":"2021","unstructured":"Sardaremelli S, Hasanzadeh M, Seidi F. Enzymatic recognition of hydrogen peroxide (H(2) O(2) ) in human plasma samples using HRP immobilized on the surface of poly(arginine-toluidine blue)- Fe(3) O(4) nanoparticles modified polydopamine; a novel biosensor. J Mol Recognit. 2021, 34:e2928. 10.1002\/jmr.2928","journal-title":"J Mol Recognit"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1109\/MCSE.2010.27","article-title":"OpenMM: a hardware independent framework for molecular simulations","volume":"12","author":"Eastman P","year":"2015","unstructured":"Eastman P, Pande VS. OpenMM: a hardware independent framework for molecular simulations. Comput Sci Eng. 2015, 12:34-9. 10.1109\/MCSE.2010.27","journal-title":"Comput Sci Eng"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/427594-in-silico-development-of-a-targeted-small-interfering-rna-sirna-sequence-to-silence-goblet-cell-mucin-5ac-overexpression-in-cystic-fibrosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T15:40:21Z","timestamp":1763912421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/427594-in-silico-development-of-a-targeted-small-interfering-rna-sirna-sequence-to-silence-goblet-cell-mucin-5ac-overexpression-in-cystic-fibrosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.97562","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,23]]}}}